Colgate High Fluoride Dentifrice
Natural health product licensed in Canada
- Licence holder
- Colgate-Palmolive Canada Inc.
- NPN or DIN-HM
- 80120491
- Status
- Active licence
- Licence date
- 9 August 2022
- Revision date
- Not provided
- Form
- Dentifrice, pâte
- Route of administration
- Dentaire
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Monofluorophosphate de sodium Source : Monofluorophosphate de sodium | 1.1 % |
Non-medicinal ingredients
PVP, Sucralose, Pyrophosphate de tétrasodium, NA, Sacharinate de sodium, Poloxamère 338, Pyrophosphate de calcium, Bétaïne, Aqua, Silice pyrogénée, PEG-12, Saveur, Poloxamère 407, Glycérine, Lauryl sulfate de sodium, Propylène glycol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Dentifrice | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Anti-cavity/anti-caries. Prevents, fights and/or protects against cavities/caries. Reduces the incidence of cavities/caries. Helps prevent tooth decay. Effective fluoride protection. Effective decay preventive fluoride. Protects teeth from acid wear/erosion. Helps delay/slow the tooth decay process at the earliest stage before it can become a cavity. Penetrates tooth enamel to help rebuild weak spots. Helps remineralize tooth enamel. Strengthens enamel / Strengthens enamel by penetrating tooth enamel to help rebuild weak spots. Helps fortify enamel(s) weak spots.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80120491
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.